APA (7th ed.) Citation

SM, G., MS, A., H, A., K, A., AM, E., A, C., . . . RA, C. (2026). MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics. Annals of neurology, 99(2), 449. https://doi.org/10.1002/ana.78040

Chicago Style (17th ed.) Citation

SM, Greenberg, et al. "MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics." Annals of Neurology 99, no. 2 (2026): 449. https://doi.org/10.1002/ana.78040.

MLA (9th ed.) Citation

SM, Greenberg, et al. "MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics." Annals of Neurology, vol. 99, no. 2, 2026, p. 449, https://doi.org/10.1002/ana.78040.